Lifetime Attributable Risk for Breast Cancer Induced by High-Resolution Computed Tomography During COVID-19 Pandemic
Objective: The widespread utilization of high-resolution computed tomography (HRCT) for diagnosing and management of COVID-19 during the pandemic has prompted worries regarding a potential rise in future breast cancer cases. We aimed to estimate the Life Attributable Risk (LAR) of breast cancer in...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2024-12-01
|
| Series: | Journal of Family and Reproductive Health |
| Subjects: | |
| Online Access: | https://jfrh.tums.ac.ir/index.php/jfrh/article/view/2838 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850048701537452032 |
|---|---|
| author | Roya Sahebi Jafar Hassanzadeh Rezvan Ravanfar Haghighi Mehrzad Lotfi Alireza Mirahmadizadeh |
| author_facet | Roya Sahebi Jafar Hassanzadeh Rezvan Ravanfar Haghighi Mehrzad Lotfi Alireza Mirahmadizadeh |
| author_sort | Roya Sahebi |
| collection | DOAJ |
| description |
Objective: The widespread utilization of high-resolution computed tomography (HRCT) for diagnosing and management of COVID-19 during the pandemic has prompted worries regarding a potential rise in future breast cancer cases. We aimed to estimate the Life Attributable Risk (LAR) of breast cancer in Shiraz, Iran, linked to HRCT use during the COVID-19 pandemic.
Materials and methods: A cross-sectional study was conducted at Namazi Hospital in Shiraz from February 2, 2020, to December 31, 2022.The Imaging Performance Assessment of CT Scanners (ImPACT) patient dosimetry calculator was used to determine organ doses. LAR was computed utilizing the Biological Effects of Ionizing Radiation (BEIR) Committee models.
Results: The sample size was 666, with ages spanning from 15 to 95 years. 25% (168) had HRCT more than once (2 to 8 times). The mean and 95% uncertainty limits (UL) for Total LAR of breast cancer, considering both single and multiple doses of radiation exposure, was 217 (95% UL, 194-244) per 100,000 persons.
Conclusion: According to our research, the risk of potential breast cancer should not be overlooked. It is advised to use the ultra-low-dose protocol over the low-dose in HRCT. Physicians, pulmonologists, and infectious disease specialists are advised to avoid unnecessary and repeated requests for chest HRCT in a short period.
|
| format | Article |
| id | doaj-art-ad82c8b606cf4af2a760386140971ebf |
| institution | DOAJ |
| issn | 1735-8949 1735-9392 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Tehran University of Medical Sciences |
| record_format | Article |
| series | Journal of Family and Reproductive Health |
| spelling | doaj-art-ad82c8b606cf4af2a760386140971ebf2025-08-20T02:53:54ZengTehran University of Medical SciencesJournal of Family and Reproductive Health1735-89491735-93922024-12-0118410.18502/jfrh.v18i4.17429Lifetime Attributable Risk for Breast Cancer Induced by High-Resolution Computed Tomography During COVID-19 PandemicRoya Sahebi0Jafar Hassanzadeh1Rezvan Ravanfar Haghighi2Mehrzad Lotfi3Alireza Mirahmadizadeh4Student Research Committee, Shiraz University of Medical Sciences, Shiraz, IranDepartment of Epidemiology, Research Center for Health Sciences, Institute of Health, School of Health, Shiraz University of Medical Sciences, Shiraz, IranMedical Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, IranDepartment of Radiology, Medical Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, IranNon-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran Objective: The widespread utilization of high-resolution computed tomography (HRCT) for diagnosing and management of COVID-19 during the pandemic has prompted worries regarding a potential rise in future breast cancer cases. We aimed to estimate the Life Attributable Risk (LAR) of breast cancer in Shiraz, Iran, linked to HRCT use during the COVID-19 pandemic. Materials and methods: A cross-sectional study was conducted at Namazi Hospital in Shiraz from February 2, 2020, to December 31, 2022.The Imaging Performance Assessment of CT Scanners (ImPACT) patient dosimetry calculator was used to determine organ doses. LAR was computed utilizing the Biological Effects of Ionizing Radiation (BEIR) Committee models. Results: The sample size was 666, with ages spanning from 15 to 95 years. 25% (168) had HRCT more than once (2 to 8 times). The mean and 95% uncertainty limits (UL) for Total LAR of breast cancer, considering both single and multiple doses of radiation exposure, was 217 (95% UL, 194-244) per 100,000 persons. Conclusion: According to our research, the risk of potential breast cancer should not be overlooked. It is advised to use the ultra-low-dose protocol over the low-dose in HRCT. Physicians, pulmonologists, and infectious disease specialists are advised to avoid unnecessary and repeated requests for chest HRCT in a short period. https://jfrh.tums.ac.ir/index.php/jfrh/article/view/2838Breast CancerHigh-Resolution Computed Tomography (HRCT)CT ScanLifetime Attributable RiskCOVID-19 |
| spellingShingle | Roya Sahebi Jafar Hassanzadeh Rezvan Ravanfar Haghighi Mehrzad Lotfi Alireza Mirahmadizadeh Lifetime Attributable Risk for Breast Cancer Induced by High-Resolution Computed Tomography During COVID-19 Pandemic Journal of Family and Reproductive Health Breast Cancer High-Resolution Computed Tomography (HRCT) CT Scan Lifetime Attributable Risk COVID-19 |
| title | Lifetime Attributable Risk for Breast Cancer Induced by High-Resolution Computed Tomography During COVID-19 Pandemic |
| title_full | Lifetime Attributable Risk for Breast Cancer Induced by High-Resolution Computed Tomography During COVID-19 Pandemic |
| title_fullStr | Lifetime Attributable Risk for Breast Cancer Induced by High-Resolution Computed Tomography During COVID-19 Pandemic |
| title_full_unstemmed | Lifetime Attributable Risk for Breast Cancer Induced by High-Resolution Computed Tomography During COVID-19 Pandemic |
| title_short | Lifetime Attributable Risk for Breast Cancer Induced by High-Resolution Computed Tomography During COVID-19 Pandemic |
| title_sort | lifetime attributable risk for breast cancer induced by high resolution computed tomography during covid 19 pandemic |
| topic | Breast Cancer High-Resolution Computed Tomography (HRCT) CT Scan Lifetime Attributable Risk COVID-19 |
| url | https://jfrh.tums.ac.ir/index.php/jfrh/article/view/2838 |
| work_keys_str_mv | AT royasahebi lifetimeattributableriskforbreastcancerinducedbyhighresolutioncomputedtomographyduringcovid19pandemic AT jafarhassanzadeh lifetimeattributableriskforbreastcancerinducedbyhighresolutioncomputedtomographyduringcovid19pandemic AT rezvanravanfarhaghighi lifetimeattributableriskforbreastcancerinducedbyhighresolutioncomputedtomographyduringcovid19pandemic AT mehrzadlotfi lifetimeattributableriskforbreastcancerinducedbyhighresolutioncomputedtomographyduringcovid19pandemic AT alirezamirahmadizadeh lifetimeattributableriskforbreastcancerinducedbyhighresolutioncomputedtomographyduringcovid19pandemic |